UK-based immunology specialist Allergy Therapeutics has announced that the Paul Ehrlich Institut (PEI) has granted a ...

In what was a busy day for Sanofi, the French pharma major has entered into a licensing and development collaboration with ...

US health technology assessor the Institute for Clinical and Economic Review (ICER) today released a Final Evidence Report ...

US biotech Immunome has announced positive top-line results from the global pivotal Phase III RINGSIDE trial of varegacestat, ...

US clinical-stage US autoimmune drug developer Kyverna Therapeutics saw its shares leap more than 23% to $10.82 after its ...

Dren Bio, a privately held, US clinical-stage biotechnology company developing first-in-class myeloid cell engager ...

Reuters Events’ flagship European cross-functional meeting for pharma leaders shaping the industry’s commercial and ...

South Korea-based Lunit, a provider of AI for cancer diagnostics and precision oncology, has announced a deal with Japanese ...

UK based liquid medicines maker Rosemont Pharmaceuticals has appointed an American chief executive (CEO) as the business ...

UK pharma major AstraZeneca today revealed that Saphnelo (anifrolumab) has been approved in the European Union (EU) for ...

The US Food and Drug Administration (FDA) yesterday removed a key limitation on the use of real-world evidence (RWE) used in ...

AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) in combination with pertuzumab has been approved in the USA ...